Hepatitis C Viral Replication Complex
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Multiple Origins of Viral Capsid Proteins from Cellular Ancestors
Multiple origins of viral capsid proteins from PNAS PLUS cellular ancestors Mart Krupovica,1 and Eugene V. Kooninb,1 aInstitut Pasteur, Department of Microbiology, Unité Biologie Moléculaire du Gène chez les Extrêmophiles, 75015 Paris, France; and bNational Center for Biotechnology Information, National Library of Medicine, Bethesda, MD 20894 Contributed by Eugene V. Koonin, February 3, 2017 (sent for review December 21, 2016; reviewed by C. Martin Lawrence and Kenneth Stedman) Viruses are the most abundant biological entities on earth and show genome replication. Understanding the origin of any virus group is remarkable diversity of genome sequences, replication and expres- possible only if the provenances of both components are elucidated sion strategies, and virion structures. Evolutionary genomics of (11). Given that viral replication proteins often have no closely viruses revealed many unexpected connections but the general related homologs in known cellular organisms (6, 12), it has been scenario(s) for the evolution of the virosphere remains a matter of suggested that many of these proteins evolved in the precellular intense debate among proponents of the cellular regression, escaped world (4, 6) or in primordial, now extinct, cellular lineages (5, 10, genes, and primordial virus world hypotheses. A comprehensive 13). The ability to transfer the genetic information encased within sequence and structure analysis of major virion proteins indicates capsids—the protective proteinaceous shells that comprise the that they evolved on about 20 independent occasions, and in some of cores of virus particles (virions)—is unique to bona fide viruses and these cases likely ancestors are identifiable among the proteins of distinguishes them from other types of selfish genetic elements cellular organisms. -
Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: a Review
viruses Review Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: A Review Dong Joo Seo 1 and Changsun Choi 2,* 1 Department of Food Science and Nutrition, College of Health and Welfare and Education, Gwangju University 277 Hyodeok-ro, Nam-gu, Gwangju 61743, Korea; [email protected] 2 Department of Food and Nutrition, School of Food Science and Technology, College of Biotechnology and Natural Resources, Chung-Ang University, 4726 Seodongdaero, Daeduck-myun, Anseong-si, Gyeonggi-do 17546, Korea * Correspondence: [email protected]; Tel.: +82-31-670-4589; Fax: +82-31-676-8741 Abstract: Mushrooms are used in their natural form as a food supplement and food additive. In addition, several bioactive compounds beneficial for human health have been derived from mushrooms. Among them, polysaccharides, carbohydrate-binding protein, peptides, proteins, enzymes, polyphenols, triterpenes, triterpenoids, and several other compounds exert antiviral activity against DNA and RNA viruses. Their antiviral targets were mostly virus entry, viral genome replication, viral proteins, and cellular proteins and influenced immune modulation, which was evaluated through pre-, simultaneous-, co-, and post-treatment in vitro and in vivo studies. In particular, they treated and relieved the viral diseases caused by herpes simplex virus, influenza virus, and human immunodeficiency virus (HIV). Some mushroom compounds that act against HIV, influenza A virus, and hepatitis C virus showed antiviral effects comparable to those of antiviral drugs. Therefore, bioactive compounds from mushrooms could be candidates for treating viral infections. Citation: Seo, D.J.; Choi, C. Antiviral Bioactive Compounds of Mushrooms Keywords: mushroom; bioactive compound; virus; infection; antiviral mechanism and Their Antiviral Mechanisms: A Review. -
Antiviral Chemistry & Chemotherapy's Current Antiviral Agents Factfile 2006
RNA_title_sheet 22/8/06 10:13 Page 1 Antiviral Chemistry & Chemotherapy’s current antiviral agents FactFile 2006 (1st edition) The RNA viruses RNA_title_sheet 22/8/06 10:13 Page 2 RNA 22/8/06 09:31 Page 129 Antiviral Chemistry & Chemotherapy 17.3 FactFiille:: RNA viiruses Symmetrel, Mantadix Amantadine Adamantan-1-amine hydrochloride, l-adamantanamine, aman- tadine hydrochloride. Novartis References: 1,64,65 Principal target virus: Influenza A virus. Other activities: HCV. H Mode of action: M2 ion channel inhibitor. Clinical stage: Licensed. Adamantine (cyclic primary amine) derivative used for the treatment and prophylaxis of influenza A virus infections. Rapid emergence of resistence has limited it use. Sometimes used to treat HCV infection in combination with interferon and ribavirin. NH2.HCI H H Ciluprevir (1S,4R,6S,14S,18R)-7Z-14-Cyclopentyloxycarbonylamino-18-[2-(2- isopropylamino-thiazol-4-yl)-7-methoxy-quinolin-4-yloxy]-2,15 Boehringer Ingelheim (Canada) Ltd. R&D dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxylic acid, BILN 2061. References: 66,67,68,69 OMe Principal target virus: HCV Mode of action: PI Development of ciluprevir has been discontinued. Ciluprevir is a novel small molecule anti-hepatitis C compound. It is N the first in a new class of investigational antiviral drugs, HCV PIs. N H O N CH S 3 O H C H 3 O N N OH O O N O H Tamiflu Oseltamivir Ethyl ester of (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethyl- propoxy)-1-cyclohexane-1-carboxylic acid, GS4104, Ro-64-0796. -
Novel HCV Inhibitors
The UseNovel of Antivirals HCV toInhibitors Rapidly Contain Outbreaks of the Classical Swine Fever Virus Johan Neyts Rega Institute, KULeuven, Leuven Belgium Presented at the 9th Eu. Workshop on HIV & Hepatitis – 25 – 27 March 2011, Paphos, Cyprus Selective Inhibitors of HCV Replication that Target NS Proteins Presented at the 9th Eu. Workshop on HIV & Hepatitis – 25 – 27 March 2011, Paphos, Cyprus The NS2 cysteine protease NS2/3 cleavage is essential for replication and assembly N N C C Active Site 1 Active Site 2 Lorenz et al. Nature (2006) 442: 831-5 Presented at the 9th Eu. Workshop on HIV & Hepatitis – 25 – 27 March 2011, Paphos, Cyprus The HCV NS3 serine protease N-terminal domain : a serine protease in the presence of the NS4A cofactor protein C-terminal domain : RNA helicase De Francesco et al. 2001 Presented at the 9th Eu. Workshop on HIV & Hepatitis – 25 – 27 March 2011, Paphos, Cyprus NS3 protease product based inhibitors carboxy-terminal hexapeptide products as an active-site affinity anchor BILN-2061 Presented at the 9th Eu. Workshop on HIV & Hepatitis – 25 – 27 March 2011, Paphos, Cyprus Proof of concept with BILN-2061 (Ciluprevir) Lamarre et al., Nature. (2003) 426:186-9. Presented at the 9th Eu. Workshop on HIV & Hepatitis – 25 – 27 March 2011, Paphos, Cyprus Telaprevir monotherapy placebo 1250 mg q12h 450 mg q8h 750 mg q8h Reesink et al., Hepatology (2005) 42 : 234A Presented at the 9th Eu. Workshop on HIV & Hepatitis – 25 – 27 March 2011, Paphos, Cyprus The Major VX-950 and BILN2061 Resistance Mutations Do Not Cause Cross-resistance ITMN-191 Ciluprevir Lin, C. -
Middle East Respiratory Syndrome Coronavirus Ns4b Protein Inhibits Host Rnase L Activation
RESEARCH ARTICLE crossmark Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation Joshua M. Thornbrough,a* Babal K. Jha,b* Boyd Yount,c Stephen A. Goldstein,a Yize Li,a Ruth Elliott,a Amy C. Sims,c Ralph S. Baric,c,d Robert H. Silverman,b Susan R. Weissa Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USAa; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USAb; Department of Epidemiologyc and Department of Microbiology and Immunology,d University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA * Present address: Joshua M. Thornbrough, Adelphi Research Global, Doylestown, Pennsylvania, USA; Babal K. Jha, Translational Hematology & Oncology Research, Taussig Cancer Research Institute, Cleveland Clinic, Cleveland, Ohio, USA. ABSTRACT Middle East respiratory syndrome coronavirus (MERS-CoV) is the first highly pathogenic human coronavirus to emerge since severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002. Like many coronaviruses, MERS-CoV carries genes that encode multiple accessory proteins that are not required for replication of the genome but are likely involved in pathogenesis. Evasion of host innate immunity through interferon (IFN) antagonism is a critical component of viral pathogene- sis. The IFN-inducible oligoadenylate synthetase (OAS)-RNase L pathway activates upon sensing of viral double-stranded RNA (dsRNA). Activated RNase L cleaves viral and host single-stranded RNA (ssRNA), which leads to translational arrest and subse- quent cell death, preventing viral replication and spread. Here we report that MERS-CoV, a lineage C Betacoronavirus, and re- lated bat CoV NS4b accessory proteins have phosphodiesterase (PDE) activity and antagonize OAS-RNase L by enzymatically degrading 2=,5=-oligoadenylate (2-5A), activators of RNase L. -
Entry of Hepatitis B and C Viruses
VIRAL HEPATITIS FORUM Getting Close Viralto Eradication Hepatitis Forum I. Basic Getting Research Close to Eradication I. Basic Research Entry of Hepatitis B and C Viruses Seungtaek Kim Severance Biomedical Science Institute, Institute of Gastroenterology, Department of Internal Medicine, Yonsei University Col- lege of Medicine, Seoul, Korea B형과 C형 간염 바이러스에 대한 최근의 분자, 세포생물학적인 발전은 간세포를 특이적으로 감염시키는 이들 바이러스에 대한 세포 수용체의 발굴과 더불어 그들의 작용 기전에 대해 더 자세한 정보들을 제공해주고 있다. 특히 C형 간염 바이러스의 경우, 간세포의 서로 다른 곳에 위치한 세포 수용체들이 바이러스의 세포 진입시에 바이러스 표면의 당단백질과 어떤 방식으로 서로 상호 작용하며 세포 내 신호 전달 과정을 거쳐 세포 안으로 들어오게 되는지 그 기전들이 서서히 드러나고 있다. 한편, B형 간염 바이러스의 경우, 오랫동안 밝혀내지 못했던 이 바이러스의 세포 수용체인 NTCP를 최근 발굴하게 됨으로써 세포 진입에 관한 연구에 획기적인 계기를 마련하게 되었으며 동시에 이를 저해할 수 있는 새로운 항바이러스제의 개발도 활기를 띠게 되었다. 임상적으로 매우 중요한 이 두 바이러스의 세포 진입에 관한 연구는 앞으로도 매우 활발하게 이루어질 것으로 기대된다. Keywords: B형 간염 바이러스, C형 간염 바이러스, 세포 진입, 신호 전달, NTCP There are five hepatitis viruses although their classes, genomes, and modes of transmission are different from each other. Of these, hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most dangerous, life-threatening pathogens, which are also responsible for 80-90% of hepatocellular carcinoma. HBV belongs to hepadnaviridae (family) and it has double-strand DNA as its genome, however, its replication occurs via reverse transcription like retrovirus replication. In contrast, HCV belongs to flaviviridae (family) and has positive-sense, single-strand RNA as its genome. -
Dissecting Negative Regulation of Toll-Like Receptor Signaling
Review Dissecting negative regulation of Toll-like receptor signaling 1,2 1,2 1,2 Takeshi Kondo , Taro Kawai and Shizuo Akira 1 Laboratory of Host Defense, WPI Immunology Frontier Research Center, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan 2 Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan Toll-like receptors (TLRs) sense invading microbial pathogens. MyD88 is recruited to all TLRs except for pathogens and play crucial roles in the activation of TLR3 and associates with IL-1R-associated kinases (IRAKs) innate and adaptive immunity. However, excessive and TNFR-associated factor 6 (TRAF6), resulting in activa- TLR activation can disrupt immune homeostasis, and tion of canonical inhibitor of kappa light polypeptide gene may be responsible for the development of autoimmune enhancer in B-cells, kinases (IKKs) (IKKa and IKKb) and and inflammatory diseases. As such, the molecules and nuclear factor (NF)-kBs (Figure 1). In contrast, TRIF is pathways that negatively control TLR signaling have recruited to TLR3 and TLR4, leading to activation of been intensively investigated. Here, we discuss recent NF-kB as well as noncanonical IKKs (TRAF-family- insights into the negative regulation of TLR signaling, member-associated NF-kB activator (TANK) binding kinase with focus on three major mechanisms: (i) dissociation 1 (TBK1) and IKKi) and interferon (IFN) regulatory factor of adaptor complexes; (ii) degradation of signal proteins; (IRF)3 via TRAF proteins (Figure 2). TIRAP functions as a and (iii) transcriptional regulation. We also highlight sorting adapter that recruits MyD88 to TLR2 and TLR4, how pathogens negatively target TLR signaling as a whereas TRAM functions as a bridge adapter between TLR4 strategy to evade the host immune response. -
Flaviviral Ns4b, Chameleon and Jack-In-The-Box Roles in Viral
Rev. Med. Virol. 2015; 25: 205–223. Published online 1 April 2015 in Wiley Online Library (wileyonlinelibrary.com) Reviews in Medical Virology DOI: 10.1002/rmv.1835 REVIEW Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention Joanna Zmurko, Johan Neyts* and Kai Dallmeier KU Leuven, Rega Institute for Medical Research, Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy SUMMARY Dengue virus and other flaviviruses such as the yellow fever, West Nile, and Japanese encephalitis viruses are emerging vector-borne human pathogens that affect annually more than 100 million individuals and that may cause debilitating and potentially fatal hemorrhagic and encephalitic diseases. Currently, there are no specific antiviral drugs for the treat- ment of flavivirus-associated disease. A better understanding of the flavivirus–host interactions during the different events of the flaviviral life cycle may be essential when developing novel antiviral strategies. The flaviviral non-structural protein 4b (NS4b) appears to play an important role in flaviviral replication by facilitating the formation of the viral replication complexes and in counteracting innate immune responses such as the following: (i) type I IFN signaling; (ii) RNA interfer- ence; (iii) formation of stress granules; and (iv) the unfolded protein response. Intriguingly, NS4b has recently been shown to constitute an excellent target for the selective inhibition of flavivirus replication. We here review the current knowledge on NS4b. © 2015 The Authors. Reviews in Medical Virology published by John Wiley & Sons Ltd. Received: 27 October 2014; Revised: 16 February 2015; Accepted: 17 February 2015 INTRODUCTION mosquito-borne viral disease, endemic in over 100 The genus Flavivirus comprises over 70 members, countries with over three billion people at direct including important human pathogens such as risk of infection [1]. -
Mechanisms of Salmonella Attachment and Survival on In-Shell Black Peppercorns, Almonds, and Hazelnuts
UC Irvine UC Irvine Previously Published Works Title Mechanisms of Salmonella Attachment and Survival on In-Shell Black Peppercorns, Almonds, and Hazelnuts. Permalink https://escholarship.org/uc/item/5534264q Authors Li, Ye Salazar, Joelle K He, Yingshu et al. Publication Date 2020 DOI 10.3389/fmicb.2020.582202 Peer reviewed eScholarship.org Powered by the California Digital Library University of California fmicb-11-582202 October 19, 2020 Time: 10:46 # 1 ORIGINAL RESEARCH published: 23 October 2020 doi: 10.3389/fmicb.2020.582202 Mechanisms of Salmonella Attachment and Survival on In-Shell Black Peppercorns, Almonds, and Hazelnuts Ye Li1, Joelle K. Salazar2, Yingshu He1, Prerak Desai3, Steffen Porwollik3, Weiping Chu3, Palma-Salgado Sindy Paola4, Mary Lou Tortorello2, Oscar Juarez5, Hao Feng4, Michael McClelland3* and Wei Zhang1* 1 Department of Food Science and Nutrition, Illinois Institute of Technology, Bedford Park, IL, United States, 2 Division of Food Processing Science and Technology, U.S. Food and Drug Administration, Bedford Park, IL, United States, 3 Department of Microbiology and Molecular Genetics, University of California, Irvine, Irvine, CA, United States, 4 Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, IL, United States, 5 Department Edited by: of Biology, Illinois Institute of Technology, Chicago, IL, United States Chrysoula C. Tassou, Institute of Technology of Agricultural Products, Hellenic Agricultural Salmonella enterica subspecies I (ssp 1) is the leading cause of hospitalizations and Organization, Greece deaths due to known bacterial foodborne pathogens in the United States and is Reviewed by: frequently implicated in foodborne disease outbreaks associated with spices and nuts. -
Identification and Validation of Novel and More Effective Choline Kinase
www.nature.com/scientificreports OPEN Identifcation and validation of novel and more efective choline kinase inhibitors against Streptococcus pneumoniae Tahl Zimmerman1*, Valerie Chasten1, Juan Carlos Lacal2 & Salam A. Ibrahim1 Streptococcus pneumoniae choline kinase (sChoK) has previously been proposed as a drug target, yet the efectiveness of the frst and only known inhibitor of sChoK, HC-3, is in the millimolar range. The aim of this study was thus to further validate sChoK as a potential therapeutic target by discovering more powerful sChoK inhibitors. LDH/PK and colorimetric enzymatic assays revealed two promising sChoK inhibitor leads RSM-932A and MN58b that were discovered with IC50 of 0.5 and 150 μM, respectively, and were shown to be 2–4 magnitudes more potent than the previously discovered inhibitor HC-3. Culture assays showed that the minimum inhibitory concentration (MIC) of RSM- 932A and MN58b for S. pneumoniae was 0.4 μM and 10 μM, respectively, and the minimum lethal concentration (MLC) was 1.6 μM and 20 μM, respectively. Western blot monitoring of teichoic acid production revealed diferential patterns in response to each inhibitor. In addition, both inhibitors possessed a bacteriostatic mechanism of action, and neither interfered with the autolytic efects of vancomycin. Cells treated with MN58b but not RSM-932A were more sensitive to a phosphate induced autolysis with respect to the untreated cells. SEM studies revealed that MN58b distorted the cell wall, a result consistent with the apparent teichoic acid changes. Two novel and more highly potent putative inhibitors of sChoK, MN58b and RSM-932A, were characterized in this study. -
Symposium on Viral Membrane Proteins
Viral Membrane Proteins ‐ Shanghai 2011 交叉学科论坛 Symposium for Advanced Studies 第二十七期:病毒离子通道蛋白的结构与功能研讨会 Symposium on Viral Membrane Proteins 主办单位:中国科学院上海交叉学科研究中心 承办单位:上海巴斯德研究所 1 Viral Membrane Proteins ‐ Shanghai 2011 Symposium on Viral Membrane Proteins Shanghai Institute for Advanced Studies, CAS Institut Pasteur of Shanghai,CAS 30.11. – 2.12 2011 Shanghai, China 2 Viral Membrane Proteins ‐ Shanghai 2011 Schedule: Wednesday, 30th of November 2011 Morning Arrival Thursday, 1st of December 2011 8:00 Arrival 9:00 Welcome Bing Sun, Co-Director, Pasteur Institute Shanghai 9: 10 – 9:35 Bing Sun, Pasteur Institute Shanghai Ion channel study and drug target fuction research of coronavirus 3a like protein. 9:35 – 10:00 Tim Cross, Tallahassee, USA The proton conducting mechanism and structure of M2 proton channel in lipid bilayers. 10:00 – 10:25 Shy Arkin, Jerusalem, IL A backbone structure of SARS Coronavirus E protein based on Isotope edited FTIR, X-ray reflectivity and biochemical analysis. 10:20 – 10:45 Coffee Break 10:45 – 11:10 Rainer Fink, Heidelberg, DE Elektromechanical coupling in muscle: a viral target? 11:10 – 11:35 Yechiel Shai, Rehovot, IL The interplay between HIV1 fusion peptide, the transmembrane domain and the T-cell receptor in immunosuppression. 11:35 – 12:00 Christoph Cremer, Mainz and Heidelberg University, DE Super-resolution Fluorescence imaging of cellular and viral nanostructures. 12:00 – 13:30 Lunch Break 3 Viral Membrane Proteins ‐ Shanghai 2011 13:30 – 13:55 Jung-Hsin Lin, National Taiwan University Robust Scoring Functions for Protein-Ligand Interactions with Quantum Chemical Charge Models. 13:55 – 14:20 Martin Ulmschneider, Irvine, USA Towards in-silico assembly of viral channels: the trials and tribulations of Influenza M2 tetramerization. -
NSP4)-Induced Intrinsic Apoptosis
viruses Article Viperin, an IFN-Stimulated Protein, Delays Rotavirus Release by Inhibiting Non-Structural Protein 4 (NSP4)-Induced Intrinsic Apoptosis Rakesh Sarkar †, Satabdi Nandi †, Mahadeb Lo, Animesh Gope and Mamta Chawla-Sarkar * Division of Virology, National Institute of Cholera and Enteric Diseases, P-33, C.I.T. Road Scheme-XM, Beliaghata, Kolkata 700010, India; [email protected] (R.S.); [email protected] (S.N.); [email protected] (M.L.); [email protected] (A.G.) * Correspondence: [email protected]; Tel.: +91-33-2353-7470; Fax: +91-33-2370-5066 † These authors contributed equally to this work. Abstract: Viral infections lead to expeditious activation of the host’s innate immune responses, most importantly the interferon (IFN) response, which manifests a network of interferon-stimulated genes (ISGs) that constrain escalating virus replication by fashioning an ill-disposed environment. Interestingly, most viruses, including rotavirus, have evolved numerous strategies to evade or subvert host immune responses to establish successful infection. Several studies have documented the induction of ISGs during rotavirus infection. In this study, we evaluated the induction and antiviral potential of viperin, an ISG, during rotavirus infection. We observed that rotavirus infection, in a stain independent manner, resulted in progressive upregulation of viperin at increasing time points post-infection. Knockdown of viperin had no significant consequence on the production of total Citation: Sarkar, R.; Nandi, S.; Lo, infectious virus particles. Interestingly, substantial escalation in progeny virus release was observed M.; Gope, A.; Chawla-Sarkar, M. upon viperin knockdown, suggesting the antagonistic role of viperin in rotavirus release. Subsequent Viperin, an IFN-Stimulated Protein, studies unveiled that RV-NSP4 triggered relocalization of viperin from the ER, the normal residence Delays Rotavirus Release by Inhibiting of viperin, to mitochondria during infection.